Chemotherapy of metastatic colorectal cancer: Fluorouracil plus folinic acid and irinotecan or oxaliplatin

Prescrire International

Volumn 14, Issue 80, 2005, Pages 230-233

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CAPECITABINE; CETUXIMAB; CYTOTOXIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; RALTITREXED; TEGAFUR; URACIL;

ACNE; BOLUS INJECTION; CANCER GROWTH; CANCER SURVIVAL; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COLORECTAL CANCER; CONSENSUS; DIARRHEA; DISEASE SEVERITY; DRUG HYPERSENSITIVITY; FEBRILE NEUTROPENIA; HAND FOOT SYNDROME; HUMAN; HYPERBILIRUBINEMIA; METASTASIS POTENTIAL; MONOTHERAPY; MUCOSA INFLAMMATION; NAUSEA AND VOMITING; NEUROPATHY; NEUTROPENIA; PARESTHESIA; QUALITY OF LIFE; REVIEW; SIDE EFFECT; SYSTEMATIC REVIEW; THROMBOCYTOPENIA; THROMBOSIS; VOMITING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; CAMPTOTHECIN; CHEMOTHERAPY, ADJUVANT; CLINICAL TRIALS; COLORECTAL NEOPLASMS; DEOXYCYTIDINE; DRUG THERAPY, COMBINATION; FLUOROURACIL; HUMANS; LEUCOVORIN; NEOPLASM METASTASIS; ORGANOPLATINUM COMPOUNDS; QUINAZOLINES; TEGAFUR; THIOPHENES; TREATMENT OUTCOME; URACIL;

EID: 28644443362     PISSN: 11677422     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Prescrire Rédaction "Dépistage de masse organisé du cancer colorectal: des résultats en France aussi" Rev Prescrire 2004, 24 (255): 775-777.
2. Fédération nationale des centres de lutte contre le cancer "Recommandations pour la pratique clinique: standards, options et recommandations pour la prise en charge des patients atteints de cancer du côlon. Mise à jour 2003 du chapitre chimiothérapie palliative de première ligne des patients atteints d'un cancer colorectal métastatique" December 2003: 131 pages.
3. Weitz J et al. "Colorectal cancer" Lancet 2005; 365: 153-165.
4. Meyerhardt JA and Mayer RJ "Systemic therapy for colorectal cancer" N Engl J Med 2005; 352 (5): 476-487.
5. Scottish Intercollegiate Guidelines Network "Management of colorectal cancer" March 2003: 47 pages.
6. National Institute for Clinical Excellence "Improving outcomes in colorectal cancers" May 2004: 128 pages.
7. Conseil scientifique de la Fédération Francophone de Cancérologie Digestive "Que faire devant un cancer digestif en 2003? Cancer du côlon métastastique". Website http://www.u.bourgogne.fr/FFCD searched on 15 October 2004.
8. Prescrire Editorial Staff "Raltitrexed" Prescrire Int 2002; 11 (50): 190-191.
9. Prescrire Rédaction "oxaliplatine et cancer colorectal. Un élargissement d'indication non justifié" Rev Prescrire 1999; 19 (199): 659-661.
10. Prescrire Editorial Staff "Irinotécan" Prescrire Int 2001; 10 (52): 41-43.
11. Prescrire Editorial Staff "Capecitabine - tegafur + uracil" Prescrire Int 2002; 11 (58): 44-47.
12. National Institute for Clinical Excellence "The use of irinotecan, oxaliplatin and raltitrexed for the treatment of advanced colorectal cancer" 10 January 2005: 159 pages.
13. Kocha W et al. "Oral capecitabine (Xelodao) in the first-line treatment of metastatic colorectal cancer" 5 December 2003 Program in evidence-based care - A cancer Ontario program Practice Guideline Report # 2-15: 19 pages.
14. National Institute for Clinical Excellence "A review of the evidence for the clinical and costeffectiveness of capecitabine and tegafur with uracil for the treatment of metastatic colorectal cancer" 23 September 2002: 146 pages.
15. Folprecht G and Köhne CH "The role of new agents in the treatment of colorectal cancer" Oncology 2004; 66: 1-17.
16. Cancer Care Ontario Program in Evidence-based care practice Guidelines initiative "Use of irinotecan (Camptosaro, CPT-11) combined with 5-fluorouracil and leucovorin (5FU/LV) as firstline therapy for metastatic colorectal cancer" 19 February 2003: 20 pages.
17. Goldberg RM et al. "A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer" J Clin Oncol 2004; 22 (1): 23-30.
18. Prescrire Editorial Staff "irinotécan" Prescrire Int 1996; 5 (26): 162-163.
19. Prescrire Rédaction "irinotécan et cancer colorectal: une évaluation en progrès" Rev Prescrire 1999; 19 (196): 423-425.
20. Tournigand C et al. "FOLFIRI followed by FOLFOX 6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study" J Clin Oncol 2004; 22 (2): 229-237.